Trial · NCT00932451
Adverse events365
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 365
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Crizotinib 250 mg BID | 138 | 1,066 | |
| other | Leukopenia | Blood and lymphatic system disorders | Crizotinib 250 mg BID | 101 | 1,066 | |
| other | Lymphopenia | Blood and lymphatic system disorders | Crizotinib 250 mg BID | 71 | 1,066 | |
| other | Neutropenia | Blood and lymphatic system disorders | Crizotinib 250 mg BID | 180 | 1,066 | |
| other | Bradycardia | Cardiac disorders | Crizotinib 250 mg BID | 93 | 1,006 | |
| other | Photopsia | Eye disorders | Crizotinib 250 mg BID | 96 | 1,066 | |
| other | Vision blurred | Eye disorders | Crizotinib 250 mg BID | 80 | 1,066 | |
| other | Visual impairment | Eye disorders | Crizotinib 250 mg BID | 460 | 1,066 | |
| other | Abdominal pain | Gastrointestinal disorders | Crizotinib 250 mg BID | 118 | 1,066 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Crizotinib 250 mg BID | 106 | 1,066 | |
| other | Constipation | Gastrointestinal disorders | Crizotinib 250 mg BID | 475 | 1,066 | |
| other | Diarrhoea | Gastrointestinal disorders | Crizotinib 250 mg BID | 548 | 1,066 | |
| other | Dyspepsia | Gastrointestinal disorders | Crizotinib 250 mg BID | 81 | 1,066 | |
| other | Dysphagia | Gastrointestinal disorders | Crizotinib 250 mg BID | 56 | 1,066 | |
| other | Nausea | Gastrointestinal disorders | Crizotinib 250 mg BID | 603 | 1,066 | |
| other | Vomiting | Gastrointestinal disorders | Crizotinib 250 mg BID | 565 | 1,066 | |
| other | Asthenia | General disorders | Crizotinib 250 mg BID | 156 | 1,066 | |
| other | Chest pain | General disorders | Crizotinib 250 mg BID | 105 | 1,066 | |
| other | Fatigue | General disorders | Crizotinib 250 mg BID | 326 | 1,066 | |
| other | Oedema | General disorders | Crizotinib 250 mg BID | 96 | 1,066 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00932451/events